CAS No. |
147438-27-5 |
中文名称 |
(S)-1-(2-((2R,3R,6S)-2-羟基-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-羟基-22-((1S,3R,4R)-4-羟基-3-甲氧基环己基)-2,13-二甲氧基-3,9,11,15,17,21-六甲基-12,18-二氧代二十二碳-3,5,7,15,19-五烯-1-基)-3-甲基四氢-2H-吡喃-2-基)-2-氧代乙酰基)哌啶-2-羧酸 |
英文名称 |
(S)-1-(2-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid |
别名 |
Secorapamycin A(Seco Rapamycin);Secorapamycin A;(Synonyms: Secorapamycin A);Seco Rapamycin2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-, (2E...;Secorapamycin A, Technical Grade
DISCONTINUED PLEASE SEE R124010;Rapamycin Impurity 23;Metamitron Impurity 4 |
标准英文名 |
(S)-1-(2-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid |
分子式 |
C51H79NO13 |
分子量 |
914.19
|
精确分子量 |
913.56
|
SMILES |
CO[C@@H](C[C@@H]1CC[C@@H](C)[C@](O)(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O1)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]1CC[C@@H](O)[C@H](OC)C1 |
标准SMILES |
C/C(=C\[C@@H](C)C(=O)/C=C/[C@H](C)C[C@H]1C[C@@H](OC)[C@H](O)CC1)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)/[C@H](C[C@@H]1CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@H]1C(O)=O)OC |
用途 |
SecoRapamycin A is a ring-opened metabolite of Rapamycin and exhibits minimal effect on mTOR function; it serves as a metabolic intermediate that can be converted to dihydroSirolimus (M2) in human liver, jejunal mucosal, and Caco-2 cell homogenates in an NADPH-dependent manner; it is used in studies investigating the metabolic disposition and transport mechanisms of Rapamycin derivatives in human tissues and intestinal cell models. |
InChIKey |
ZAVMPSVOEQNVCP-FWSQOCJKSA-N |